This case emphasizes the need for regular pulmonary screening in all JDM patients, regardless of their antibody profile, and suggests that our understanding of the protective role of TIF1-γ against pulmonary fibrosis requires further investigation. Here, TRIM33 is linked to juvenile dermatomyositis.